Clinigen acquisition of Quantum Pharma approved
Clinigen's acquisition of AIM peer Quantum Pharma, a manufacturer and supplier of unlicensed medicines and special obtain products, was approved on Tuesday.
Clinigen Group
925.00p
16:39 04/04/22
0.00%
0.00p
Food & Drug Retailers
3,914.51
17:14 28/03/24
0.39%
15.30
FTSE AIM 100
3,604.12
16:44 28/03/24
n/a
n/a
FTSE AIM 50
3,992.86
16:44 28/03/24
n/a
n/a
FTSE AIM All-Share
743.26
16:50 28/03/24
n/a
n/a
Cancellation of trading of the Quantum shares on AIM will take place on 2 November.